1. Dual-vector nanoengineered mRNA-CRISPR delivery systems for precision gene therapy in choroidal melanoma
Thakur Sk, Malviya R, Chandra P, Sridhar Sb, Shareef J, Wadhwa T
Choroidal melanoma is the most common primary intraocular malignancy, and effective gene therapy remains limited by ocular barriers, tumor heterogeneity, and inefficient nucleic acid delivery. This review critically analyses the molecular rationale, engineering principles, emerging nanoarchitectures, biological…
- CRISPR-Cas genome editing
- Choroidal melanoma
- Ocular nanomedicine
- dual-vector nanoengineering
- gene therapy
- mRNA therapeutics
- nucleic acid delivery
